283 related articles for article (PubMed ID: 30759233)
21. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
22. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
[TBL] [Abstract][Full Text] [Related]
23. Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion.
Allon MA; Leach RE; Dunbar J; Diamond MP
Fertil Steril; 2005 Apr; 83 Suppl 1():1319-26. PubMed ID: 15831308
[TBL] [Abstract][Full Text] [Related]
24. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
Ruchhoft EA; Elkind-Hirsch KE; Malinak R
Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
[TBL] [Abstract][Full Text] [Related]
25. Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance.
Morishita M; Endo T; Baba T; Kuno Y; Ikeda K; Kiya T; Honnma H; Saito T
J Ovarian Res; 2018 Mar; 11(1):24. PubMed ID: 29580285
[TBL] [Abstract][Full Text] [Related]
26. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
27. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
Chen MJ; Yang WS; Chen CL; Wu MY; Yang YS; Ho HN
Hum Reprod; 2008 Apr; 23(4):952-7. PubMed ID: 18256110
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome.
Takayama K; Fukaya T; Sasano H; Funayama Y; Suzuki T; Takaya R; Wada Y; Yajima A
Hum Reprod; 1996 Jul; 11(7):1387-92. PubMed ID: 8671472
[TBL] [Abstract][Full Text] [Related]
29. Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.
Shobokshi A; Shaarawy M
J Soc Gynecol Investig; 2003 Feb; 10(2):99-104. PubMed ID: 12593999
[TBL] [Abstract][Full Text] [Related]
30. Best methods for identification and treatment of PCOS.
Artini PG; Di Berardino OM; Simi G; Papini F; Ruggiero M; Monteleone P; Cela V
Minerva Ginecol; 2010 Feb; 62(1):33-48. PubMed ID: 20186113
[TBL] [Abstract][Full Text] [Related]
31. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.
Loverro G; Vicino M; Lorusso F; Vimercati A; Greco P; Selvaggi L
Gynecol Endocrinol; 2001 Apr; 15(2):142-9. PubMed ID: 11379011
[TBL] [Abstract][Full Text] [Related]
32. The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome.
Dewailly D; Catteau-Jonard S; Reyss AC; Maunoury-Lefebvre C; Poncelet E; Pigny P
Hum Reprod; 2007 Jun; 22(6):1562-6. PubMed ID: 17449514
[TBL] [Abstract][Full Text] [Related]
33. Potential utility of insulin sensitizers in the treatment of patients with Polycystic ovary syndrome.
Bayram F; Unluhizarci K; Kelestimur F
Treat Endocrinol; 2002; 1(1):45-53. PubMed ID: 15765620
[TBL] [Abstract][Full Text] [Related]
34. Defective CFTR-regulated granulosa cell proliferation in polycystic ovarian syndrome.
Chen H; Guo JH; Zhang XH; Chan HC
Reproduction; 2015 May; 149(5):393-401. PubMed ID: 25646509
[TBL] [Abstract][Full Text] [Related]
35. Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis.
Brown RJ; Joseph J; Cochran E; Gewert C; Semple R; Gorden P
J Clin Endocrinol Metab; 2017 Jun; 102(6):1789-1791. PubMed ID: 27911591
[TBL] [Abstract][Full Text] [Related]
36. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.
Ibanez L; Potau N; Zampolli M; Prat N; Virdis R; Vicens-Calvet E; Carrascosa A
J Clin Endocrinol Metab; 1996 Mar; 81(3):1237-43. PubMed ID: 8772605
[TBL] [Abstract][Full Text] [Related]
37. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.
Lima PDA; Nivet AL; Wang Q; Chen YA; Leader A; Cheung A; Tzeng CR; Tsang BK
Biol Reprod; 2018 Oct; 99(4):838-852. PubMed ID: 29688269
[TBL] [Abstract][Full Text] [Related]
38. Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction.
Filicori M; Flamigni C; Cognigni G; Dellai P; Michelacci L; Arnone R
Fertil Steril; 1994 Aug; 62(2):279-85. PubMed ID: 8034073
[TBL] [Abstract][Full Text] [Related]
39. PCOS in adolescence and type 2 diabetes.
Carreau AM; Baillargeon JP
Curr Diab Rep; 2015 Jan; 15(1):564. PubMed ID: 25398203
[TBL] [Abstract][Full Text] [Related]
40. Which treatment options should be used in adolescents with polycystic ovary syndrome?
Villa P; Di Sebastiano F; Rossodivita A; Sagnella F; Barini A; Fulghesu AM; Lanzone A
J Pediatr Endocrinol Metab; 2004 May; 17(5):705-10. PubMed ID: 15237703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
